As health care costs continue to rise, manufacturers need clearer answers on how the federal 340B drug pricing program affects employer-sponsored health plans.
The Ohio Manufacturers’ Association has warned that proposals to expand 340B in Ohio could raise employer costs without showing that patients are seeing the savings. OMA has also noted that Ohio employers already absorb an estimated $275 million a year in added 340B-related costs.
To help members better understand the issue, OMA will host a special member briefing Monday, June 29, from 1:30 to 2:30 p.m. via Zoom. Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, will join OMA staff to explain how 340B works, its impact on employer-sponsored coverage and current policy developments in Ohio. The briefing will also include a demonstration of the National Alliance’s 340B Employer Cost Impact Calculator.
“Ohio employers are already paying more for health coverage, and 340B is a fast-growing issue they need to understand,” said James Lee, OMA managing director of public policy services. “This briefing will give manufacturers a practical look at how the program affects their plans, what is happening in Ohio and what questions they should be asking.”
Register today to join the briefing. 6/25/2026